How large is the stroke diagnostic and therapeutic market, and what is its growth trajectory?
The stroke diagnostic and therapeutic market size has grown strongly in recent years. It will grow from $33.41 billion in 2024 to $36.36 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rising government funding and programs, development in access to healthcare services, rapid urbanization, growing better healthcare facilities, and the rapid expansion of telemedicine and tele-stroke services.
The stroke diagnostic and therapeutic market size is expected to see strong growth in the next few years. It will grow to $50.37 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to the surge in cases of diabetes, the rising number of patients with high blood pressure, increasing the number of patients at risk of developing stroke, raising awareness about stroke prevention, the increasing incidence and prevalence of stroke cases. Major trends in the forecast period include the increasing adoption of artificial intelligence (ai) and machine learning (ml) algorithms, advancement in power instruments, ongoing healthcare technology advancements, development in rapid and accurate diagnostic tools, and development in telemedicine and tele-stroke services.
Get Your Free Sample of The Global Stroke Diagnostic And Therapeutic Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20654&type=smp
What are the key forces behind the stroke diagnostic and therapeutic market’s growth in recent years?
The increasing prevalence of stroke cases are expected to propel the growth of the stroke diagnostic and therapeutic market going forward. Stroke refers to a medical emergency that occurs when blood flow to a part of the brain is interrupted or reduced, depriving brain tissue of oxygen and nutrients, which can lead to brain cell damage or death. Hypertension increases stroke risk by damaging blood vessels, making them more susceptible to rupture or blockage. The effectiveness of stroke diagnostics and therapeutics crucially influences patient outcomes, as quick diagnosis and timely treatment can significantly reduce brain damage, disability, and mortality. For instance, in January 2024, according to a report published by the American Heart Association, a US-based nonprofit organization, stroke was responsible for 7.44 million deaths globally, with 3.71 million from ischemic stroke, 3.38 million from intracerebral hemorrhage, and 0.36 million from subarachnoid hemorrhage in 2021. Furthermore, in January 2023, according to a report published by the American Heart Association, a US-based nonprofit organization, there were 7.08 million deaths due to stroke, including 3.48 million from ischemic stroke, 3.25 million from intracerebral hemorrhage, and 0.35 million from subarachnoid hemorrhage. Therefore, the increasing prevalence of stroke cases are driving the growth of the stroke diagnostic and therapeutic market.
What are the major segments of the stroke diagnostic and therapeutic market?
The stroke diagnostic and therapeutic market covered in this report is segmented –
1) By Type: Diagnostics, Therapeutics
2) By Stroke Prevention Strategies: Medication Management, Lifestyle Modifications, Surgical Interventions
3) By Application: Hemorrhagic Stroke, Ischemic Stroke
Subsegments:
1) By Diagnostics: Imaging Techniques, Blood Tests And Biomarker Analysis, Ultrasound Imaging, Neuroimaging Devices, Stroke Risk Assessment Tools
2) By Therapeutics: Thrombolytic Medications, Antiplatelet Agents, Anticoagulants, Surgical Interventions, Rehabilitation Devices And Therapy Solutions, Neuromodulation Therapies
Order your report now for swift delivery
Which companies dominate the stroke diagnostic and therapeutic market?
Major companies operating in the stroke diagnostic and therapeutic market are Johnson & Johnson Service Inc., Bayer AG, Abbott Laboratories, Medtronic plc, Boehringer Ingelheim International GmbH, Siemens Healthineers AG, Koninklijke Philips N. V., Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Genentech Inc., Nihon Kohden Corporation, MicroPort Scientific Corporation, Penumbra Inc., ASAHI INTECC CO. LTD., Silk Road Medical Inc., RapidAI, Pharmazz Inc., Medfield Diagnostics AB, Perfuze Limited, Qure.ai Technologies Private limited
What major trends will shape the stroke diagnostic and therapeutic market during the forecast period?
Major companies operating in the stroke diagnostic and therapeutic market are developing advanced AI-based healthcare platforms to improve the accuracy and efficiency of stroke diagnosis and treatment. An AI-based healthcare platform utilizes artificial intelligence to analyze extensive patient data, detect patterns, and offer insights, aiming to improve diagnostic accuracy, treatment efficiency, and personalized care. For instance, in November 2023, RapidAI, a US-based provider of artificial intelligence (AI) and technology, launched Rapid Edge Cloud. The platform is a hybrid structure that combines cloud and on-premise technologies to improve speed, security, and flexibility. It smoothly connects with hospital and third-party applications and has received Class III Shonin clearance in Japan, the world’s second-largest stroke market. Rapid is Japan’s first advanced stroke imaging platform that supports mechanical thrombectomy determination, and it provides unique MR-based perfusion capabilities. Its AI-powered non-contrast CT solutions, such as Rapid NCCT Stroke, Rapid ASPECTS, Rapid Hypodensity, Rapid Hyperdensity, and Rapid SDH, are the only ones that detect suspected stroke cases during the initial CT scan, significantly reducing decision and treatment times and improving patient outcomes.
What are the key regional dynamics of the stroke diagnostic and therapeutic market, and which region leads in market share?
North America was the largest region in the stroke diagnostic and therapeutic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stroke diagnostic and therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Stroke Diagnostic And Therapeutic Market Report 2025 Offer?
The stroke diagnostic and therapeutic market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Stroke diagnostics and therapeutics encompass the tools and techniques used to detect and address strokes. Diagnostic methods help visualize brain damage and determine the stroke type. Therapeutic strategies focus on medical treatments and procedures to restore blood flow, minimize brain injury, and aid in patient rehabilitation. The primary aim is to promptly identify strokes and provide effective treatment to reduce long-term disability and enhance patient recovery.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20654
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
